BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11360750)

  • 41. Prospective estimation of rates of change in mammographic parenchymal patterns: influence of age and of hormone replacement therapy.
    Myles JP; Salmininen T; Duffy SW; Prevost TC; Day NE; Hakama M
    Breast; 2004 Feb; 13(1):56-60. PubMed ID: 14759717
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
    Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
    Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of hormone replacement therapy (HRT) and survival following breast cancer diagnosis.
    Fletcher AS; Erbas B; Kavanagh AM; Hart S; Rodger A; Gertig DM
    Breast; 2005 Jun; 14(3):192-200. PubMed ID: 15927828
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Mammographic breast density and breast cancer risk during HRT].
    Bock K; Hadji P; Duda VF; Jackisch C; Wagner U
    Zentralbl Gynakol; 2005 Aug; 127(4):217-21. PubMed ID: 16037902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
    Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
    Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Breast cancer in women who undergo screening mammography: relationship of hormone replacement therapy to stage and detection method.
    Roubidoux MA; Wilson TE; Orange RJ; Fitzgerald JT; Helvie MA; Packer SA
    Radiology; 1998 Sep; 208(3):725-8. PubMed ID: 9722852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Asian Menopause Survey: knowledge, perceptions, hormone treatment and sexual function.
    Huang KE; Xu L; I NN; Jaisamrarn U
    Maturitas; 2010 Mar; 65(3):276-83. PubMed ID: 20018469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Glass AG; Lacey JV; Carreon JD; Hoover RN
    J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of hormone replacement therapy on recall rate in the National Health Service Breast Screening Programme.
    Litherland JC; Evans AJ; Wilson AR
    Clin Radiol; 1997 Apr; 52(4):276-9. PubMed ID: 9112944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Practicing breast imaging in HRT ladies in Thailand.
    Bhothisuwan W
    J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S169-73. PubMed ID: 21213518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postmenopausal hormone therapy and mammographic breast density.
    Marchesoni D; Driul L; Ianni A; Fabiani G; Della Martina M; Zuiani C; Bazzocchi M
    Maturitas; 2006 Jan; 53(1):59-64. PubMed ID: 15939560
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systematic review about breast cancer incidence in relation to hormone replacement therapy use.
    Antoine C; Ameye L; Paesmans M; Rozenberg S
    Climacteric; 2014 Apr; 17(2):116-32. PubMed ID: 23909434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An interesting byproduct of screening: assessing the effect of HRT on arterial calcification in the female breast.
    Cox J; Simpson W; Walshaw D
    J Med Screen; 2002; 9(1):38-9. PubMed ID: 11943796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Breast density: a major parameter to follow during hormone replacement therapy].
    Gairard B; Guldenfels C; Haehnel P; Mathelin C
    Gynecol Obstet Fertil; 2009; 37(7-8):657-60. PubMed ID: 19577502
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
    Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
    Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins.
    Topal NB; Ayhan S; Topal U; Bilgin T
    J Obstet Gynaecol Res; 2006 Jun; 32(3):305-8. PubMed ID: 16764621
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hormone Replacement Therapy, Breast Cancer Risk Factors, and Breast Cancer Risk: A Nationwide Population-Based Cohort.
    Yoo TK; Han KD; Kim D; Ahn J; Park WC; Chae BJ
    Cancer Epidemiol Biomarkers Prev; 2020 Jul; 29(7):1341-1347. PubMed ID: 32299849
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Changes in mammography and breast ultrasonography in women undergoing hormonal replacement therapy].
    Rzymski P; Szpakowska-Rzymska I; Wilczak M; Warenik-Szymankiewicz A; Sajdak S
    Ginekol Pol; 2001 Oct; 72(10):809-15. PubMed ID: 11848018
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hormones and mammographic breast density.
    Warren R
    Maturitas; 2004 Sep; 49(1):67-78. PubMed ID: 15351098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.